Clinical Trial: Optimising TREATment for Severe Gram-Negative Bacterial Infections

U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07004049) titled 'Optimising TREATment for Severe Gram-Negative Bacterial Infections' on April 29.

Brief Summary: TREAT-GNB is an innovative trial to expedite the evaluation of various antibiotic choices and treatment strategies for severe multidrug-resistant Gram-negative bacterial infections, specifically bloodstream and lower respiratory tract infections. This approach combines platform trial elements with adaptive clinical designs to streamline the evaluation of various treatment options and optimise resource utilisation. The overall aim of the TREAT-GNB platform trial is to identify interventions that improve survival in patients with severe infe...